Medications like Ozempic and Wegovy, discussed by doctors at Mountain View Hospital and Idaho Falls Community Hospital, mimic the gut hormone GLP-1 to provide sustained appetite and blood sugar control.
These drugs help people feel full longer, reduce cravings, and were originally developed for type 2 diabetes before their weight loss benefits were discovered.
GLP-1 medications may also affect reward pathways in the brain, with ongoing research into their potential for treating addiction, but appetite and weight often return after stopping the medication.
Will the experimental drug TIX100 finally offer a permanent solution to weight regain after stopping Ozempic?
Could Ozempic-like drugs become a common treatment for addiction, arthritis, and kidney disease?
Can a genetic test now predict my success and side effects on weight-loss drugs like Wegovy?
Is Eli Lilly’s upcoming daily pill a true game-changer compared to the new oral Wegovy?
Are new weight-loss drugs creating a major health gap between the rich and poor?
What are the unknown risks of taking powerful hormone-mimicking drugs for life?